U.S. Medical Equipment Stock News

Earlier this month, EQT Corporation launched a cash tender offer of up to US$1.15 billion to repurchase several series of its outstanding senior notes and also disclosed plans to redeem all of its 6.500% Senior Notes due 2027. By retiring multiple tranches of bonds and potentially using both cash on hand and its revolving credit facility, EQT is actively reshaping its debt profile and interest burden. Next, we’ll explore how EQT’s move to pare back over US$1.15 billion of debt could affect...

What recent performance says about Lionsgate Studios shares Lionsgate Studios (LION) has drawn attention after recent trading, with the share price around $9.22 and returns spanning a 3.3% decline over 1 day and a 5.1% decline over the past week. Over the past month, the stock shows an 8.0% gain and about an 11.0% gain over the past 3 months. The year-to-date move is a modest 0.9% decline, giving investors a mixed short-term picture. See our latest analysis for Lionsgate Studios. Short term,...

If you are wondering whether Freeport-McMoRan’s current share price lines up with its underlying worth, this breakdown will help you connect the dots between market moves and valuation. The stock most recently closed at US$52.09, with returns of 31.2% over 1 year and 0.3% year to date, alongside shorter term moves of a 7.6% decline over 7 days and a 16.7% decline over 30 days that may reflect changing expectations or risk perceptions. Recent headlines around Freeport-McMoRan have focused on...

Joby Aviation (JOBY) has drawn fresh attention after recent trading left the stock around $9.23, with returns under pressure over the past month and the past 3 months. This has prompted investors to reassess expectations. See our latest analysis for Joby Aviation. At around $9.23, the recent 1 day and 7 day share price declines, along with a 30 day share price return of 8.52% and a 90 day share price return of 35.09%, contrast with a 1 year total shareholder return of 39.01% and a 3 year...

If you are wondering whether Visa's current share price offers good value or not, it helps to separate short term noise from what the market is really pricing in. Visa shares last closed at US$301.62, with returns of a 1.8% decline over 7 days, a 5.8% decline over 30 days, and a 12.9% decline year to date. The 1 year return sits at a 9.5% decline, alongside longer term gains of 39.6% over 3 years and 46.5% over 5 years. Recent coverage around Visa has focused on its role at the center of...

Why 3M Stock Is Drawing Attention Now 3M (MMM) has been on investors’ radars after a period where the share price showed negative returns over the past month and past 3 months, prompting fresh questions about how to think about the stock today. See our latest analysis for 3M. At around $141.20 per share, 3M’s recent 7 day and 30 day share price returns of 6.47% and 13.99% declines suggest fading short term momentum. However, the 3 year total shareholder return of 85.06% reflects a very...

Recent performance and valuation snapshot QCR Holdings (QCRH) has attracted fresh attention after recent share price moves, with the stock showing a 0.3% gain over the past day but an 11.3% decline over the past month. Over the past 3 months, the share price shows a 4.6% decline, while the 1 year total return stands at 14.1%. The 3 year total return is 8.8x, and the 5 year total return is 74.9%. See our latest analysis for QCR Holdings. At a share price of $81.62, QCR Holdings has seen short...

Investors may be wondering if Lattice Semiconductor at around US$88.62 is still good value after its strong run, or if the market has already priced in most of the opportunity. The stock has seen mixed recent returns, with a 3.3% gain over the last 7 days, an 8.9% decline over 30 days, and returns of 12.7% year to date and 46.1% over 1 year. These moves sit against a backdrop of ongoing interest in semiconductor names. Investors have been watching how companies like Lattice position their...

Wondering whether Progressive at around US$206 still offers value or is pricing in too much optimism? This article breaks down what the current share price could be implying. The stock has inched up 0.4% over the last 7 days and 1.3% over the last 30 days, although it is still showing a 2.9% decline year to date and a 19.6% decline over the last year, set against longer term returns of 60.6% over 3 years and 142.0% over 5 years. Recent coverage has focused on Progressive's position within...

Wondering if Brookfield Infrastructure Partners at around US$36.47 still offers value, or if most of the easy gains are already behind it? This article walks through the key numbers so you can judge that for yourself. The unit price has been mixed in the short term, with a 3.4% decline over the last week and a 4.7% decline over the last month, but it still sits on a 6.3% year to date gain and a 33.5% return over the past year. Recent attention on Brookfield Infrastructure Partners has...

Many investors are asking whether Nextpower is still attractively priced after its strong recent run, or whether most of the easier gains may already have been realized. The stock recently closed at US$114.39, with returns of 23.3% year to date and 158.4% over the last year. Over the past week and month, however, it has declined 4.4% and 1.4%, respectively. Recent coverage has focused on how the 1-year return of 158.4% compares with longer term performance of 266.6% over 3 years, providing...

If you are wondering whether CBIZ's share price now reflects its true worth, the starting point is understanding how that price lines up against different measures of value. The stock recently closed at US$27.02, with returns of 3.4% over the last week, a 9.5% decline over the past month, and longer term returns of a 46.8% decline year to date and a 63.0% decline over the past year. These moves sit against a backdrop where investors have been reassessing many professional services names,...

On March 19, 2026, Guggenheim initiated coverage of Automatic Data Processing (ADP) with a Buy rating as management raised its fiscal 2026 revenue and adjusted EPS growth outlook on the Q4 2025 earnings call. This combination of fresh analyst coverage and upgraded guidance highlights how ADP’s diversified business mix may help address investor concerns about AI-related pressures on software vendors. We’ll now examine how ADP’s upgraded 2026 outlook, underpinned by share repurchases,...

KLA Corporation recently raised its quarterly dividend to US$2.30 per share from US$1.90 and expanded its share repurchase authorization by US$7.00 billion to a total of US$20.00 billion, marking its 17th consecutive annual dividend increase. These larger cash returns to shareholders highlight KLA's confidence in its cash generation and capital allocation framework at a time of accelerating AI-related demand. Next, we’ll explore how KLA’s richer dividend and expanded buyback program reshape...

AeroVironment (NasdaqGS:AVAV) recently featured on a major U.S. news program for its laser defense systems aimed at countering international drone threats. The company secured more than US$1b in new long term defense contracts, significantly expanding its backlog. These wins arrived alongside a record goodwill impairment and financial guidance that some investors viewed as underwhelming. AeroVironment is best known for unmanned aerial systems, and its advanced laser defense technology...

Pathward Financial recently reported a softer quarter in which revenue and net interest income came in below analysts’ expectations, prompting investors to reassess its recent performance. Despite the miss, CEO Brett Pharr reiterated confidence in Pathward’s banking‑as‑a‑service strategy and signaled an emphasis on sustainable growth heading into fiscal 2026. We’ll now examine how the earnings miss, alongside management’s reaffirmed confidence, may reshape Pathward Financial’s longer-term...

If you are wondering whether Regeneron Pharmaceuticals at around US$732.87 is still offering value or starting to look expensive, you are asking the right question. The stock has seen mixed returns, with an 11.9% gain over the last year but declines of 1.7% over the past week, 6.3% over the past month, and 5.6% year to date. These moves can change how the market views its growth potential and risk. Recent coverage of Regeneron Pharmaceuticals has kept attention on the business and its...

Investors may be wondering whether Urban Outfitters, at around US$63 a share, is still a sensible entry point or addition to a portfolio, or if the easy value has already been taken. The stock is up 29.0% over the last year and 139.1% over three years, even though it is 15.9% lower year to date and 9.6% lower over the last month. Recent coverage has focused on Urban Outfitters as a specialty retail name that has attracted attention after a strong multi year run. More recent pullbacks have...

If you are wondering whether McKesson at around US$885.84 is still offering fair value or starting to look stretched, this article walks through the key numbers that matter. The stock price has moved by a 5.9% decline over the past week and a 6.5% decline over the past month, set against a 7.6% gain year to date and a 34.5% return over the last year, which may have shifted how the market is thinking about its risk and reward profile. Recent headlines around McKesson have focused on its role...

Why Parker-Hannifin (PH) is on investors’ radar today Parker-Hannifin (PH) has drawn fresh attention after a mixed stretch in its share performance, with a 10.33% decline over the past month contrasted by a 2.24% gain in the past 3 months. See our latest analysis for Parker-Hannifin. At a share price of $894.41, Parker-Hannifin’s recent 1 day and 30 day share price declines sit against a much stronger 1 year and multi year total shareholder return. This suggests that momentum has cooled after...

Bright Horizons Family Solutions (BFAM) is in the spotlight after announcing plans to close 45 to 50 underperforming centers in 2026, while investigations begin and management leans harder into its higher margin back up care business. See our latest analysis for Bright Horizons Family Solutions. Those center closures and the fresh securities investigations come after a sharp reset in sentiment. A 30 day share price return of 9.12% contrasts with a 90 day share price return decline of 23.91%...

Western Digital (WDC) has been caught in a sharp pullback as Middle East tensions, higher oil prices, and fresh US charges tied to AI chip smuggling ripple through high-growth technology names. See our latest analysis for Western Digital. The latest pullback comes after Western Digital’s share price climbed sharply, with a 90 day share price return of 61.86% and a very large 1 year total shareholder return that points to powerful, but volatile, momentum. If the recent swings in storage and AI...

Recent performance snapshot for Definium Therapeutics (DFTX) Definium Therapeutics (NasdaqGS:DFTX) has drawn attention after a past 3 months total return of 44.9% and a 1 year total return above 100%. This has prompted closer scrutiny of its clinical stage risk and valuation. See our latest analysis for Definium Therapeutics. The recent 90 day share price return of 44.9% and very large 3 year total shareholder return suggest momentum has been building, even though the latest 1 day move showed...

What the recent share performance signals for Bath & Body Works (BBWI) Recent trading in Bath & Body Works (BBWI) has drawn attention, with the stock showing a 4.5% decline over the past day and a month return of about 18.8% lower, alongside weaker past year and 3 year total returns. See our latest analysis for Bath & Body Works. The recent 30 day share price return of 18.8% lower and 1 year total shareholder return of 33.6% lower suggest momentum has been weak, as the current share price of...